Search

Susan T. Tran

Examiner (ID: 18781, Phone: (571)272-0606 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1618, 1615
Total Applications
1942
Issued Applications
1080
Pending Applications
218
Abandoned Applications
663

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19497729 [patent_doc_number] => 20240336747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => METAL-GLYCEROL DECORATED ANTIMICROBIAL POLYMER COMPOSITE [patent_app_type] => utility [patent_app_number] => 18/690069 [patent_app_country] => US [patent_app_date] => 2023-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690069 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/690069
METAL-GLYCEROL DECORATED ANTIMICROBIAL POLYMER COMPOSITE Apr 23, 2023 Pending
Array ( [id] => 18806790 [patent_doc_number] => 20230381121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => N-PALMITOYLETHANOLAMIDE AND MELATONIN FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROBEHAVIORAL DISORDERS SIMILARLY ACCOMPANIED BY RESTLESSNESS, IRRITABILITY, SLEEP DISORDERS, AND POTENTIALLY STEREOTYPIES [patent_app_type] => utility [patent_app_number] => 18/303789 [patent_app_country] => US [patent_app_date] => 2023-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18303789 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/303789
N-PALMITOYLETHANOLAMIDE AND MELATONIN FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROBEHAVIORAL DISORDERS SIMILARLY ACCOMPANIED BY RESTLESSNESS, IRRITABILITY, SLEEP DISORDERS, AND POTENTIALLY STEREOTYPIES Apr 19, 2023 Pending
Array ( [id] => 18610074 [patent_doc_number] => 20230276802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Method for Controlling Hematophagous or Sap-Feeding Arthropods [patent_app_type] => utility [patent_app_number] => 18/136974 [patent_app_country] => US [patent_app_date] => 2023-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21212 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18136974 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/136974
Method for controlling hematophagous or sap-feeding arthropods Apr 19, 2023 Issued
Array ( [id] => 18836740 [patent_doc_number] => 11844797 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-12-19 [patent_title] => Combination of dextromethorphan and bupropion for treating depression [patent_app_type] => utility [patent_app_number] => 18/304246 [patent_app_country] => US [patent_app_date] => 2023-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5121 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18304246 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/304246
Combination of dextromethorphan and bupropion for treating depression Apr 19, 2023 Issued
Array ( [id] => 19477066 [patent_doc_number] => 20240325108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => DRUG-REFILLABLE, BIOCOMPATIBLE, AND BIODEGRADABLE TISSUE MARKERS AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/194007 [patent_app_country] => US [patent_app_date] => 2023-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12615 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194007 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/194007
DRUG-REFILLABLE, BIOCOMPATIBLE, AND BIODEGRADABLE TISSUE MARKERS AND METHODS OF MAKING AND USING THE SAME Mar 30, 2023 Pending
Array ( [id] => 18522802 [patent_doc_number] => 20230233451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => OSMOTIC DRUG DELIVERY IMPLANTS [patent_app_type] => utility [patent_app_number] => 18/127214 [patent_app_country] => US [patent_app_date] => 2023-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18127214 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/127214
OSMOTIC DRUG DELIVERY IMPLANTS Mar 27, 2023 Pending
Array ( [id] => 18672867 [patent_doc_number] => 20230310313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE [patent_app_type] => utility [patent_app_number] => 18/119192 [patent_app_country] => US [patent_app_date] => 2023-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23430 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119192 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/119192
THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE Mar 7, 2023 Abandoned
Array ( [id] => 18496023 [patent_doc_number] => 20230218552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => Acetaminophen Formulation With Protection Against Toxic Effects of Overdose [patent_app_type] => utility [patent_app_number] => 18/175212 [patent_app_country] => US [patent_app_date] => 2023-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175212 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/175212
Acetaminophen Formulation With Protection Against Toxic Effects of Overdose Feb 26, 2023 Abandoned
Array ( [id] => 19608055 [patent_doc_number] => 12156914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Pharmaceutical compositions comprising bupropion and cysteine [patent_app_type] => utility [patent_app_number] => 18/169402 [patent_app_country] => US [patent_app_date] => 2023-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3733 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169402 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/169402
Pharmaceutical compositions comprising bupropion and cysteine Feb 14, 2023 Issued
Array ( [id] => 20437350 [patent_doc_number] => 12508171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-30 [patent_title] => Delivery systems for control of bleeding in transurethral prostatectomy [patent_app_type] => utility [patent_app_number] => 18/160953 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 50 [patent_no_of_words] => 17334 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160953 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160953
Delivery systems for control of bleeding in transurethral prostatectomy Jan 26, 2023 Issued
Array ( [id] => 20212529 [patent_doc_number] => 12409163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Method of enhancing 5-hydroxytryptophan (5-HTP) exposure [patent_app_type] => utility [patent_app_number] => 18/102471 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 33 [patent_no_of_words] => 19603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102471 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/102471
Method of enhancing 5-hydroxytryptophan (5-HTP) exposure Jan 26, 2023 Issued
Array ( [id] => 18404543 [patent_doc_number] => 20230165894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING PRURITIS ANI AND ANAL FISSURES [patent_app_type] => utility [patent_app_number] => 18/102014 [patent_app_country] => US [patent_app_date] => 2023-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102014 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/102014
Compositions and methods for treating pruritis ani and anal fissures Jan 25, 2023 Issued
Array ( [id] => 18647706 [patent_doc_number] => 20230293476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN [patent_app_type] => utility [patent_app_number] => 18/155240 [patent_app_country] => US [patent_app_date] => 2023-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7464 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155240 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/155240
PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN Jan 16, 2023 Abandoned
Array ( [id] => 18323197 [patent_doc_number] => 20230121325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/064383 [patent_app_country] => US [patent_app_date] => 2022-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064383 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/064383
FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS Dec 11, 2022 Pending
Array ( [id] => 20534396 [patent_doc_number] => 12551447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists [patent_app_type] => utility [patent_app_number] => 18/070341 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13088 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070341 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/070341
Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists Nov 27, 2022 Issued
Array ( [id] => 18565565 [patent_doc_number] => 20230255892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => OSMOTIC DRUG DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/991697 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/991697
OSMOTIC DRUG DELIVERY SYSTEM Nov 20, 2022 Abandoned
Array ( [id] => 19125621 [patent_doc_number] => 20240130974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => SOLID PHARMACEUTICAL TABLET [patent_app_type] => utility [patent_app_number] => 18/057119 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057119 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057119
SOLID PHARMACEUTICAL TABLET Nov 17, 2022 Abandoned
Array ( [id] => 19216192 [patent_doc_number] => 20240180896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS [patent_app_type] => utility [patent_app_number] => 18/284981 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284981 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284981
METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS Nov 16, 2022 Pending
Array ( [id] => 20301260 [patent_doc_number] => 12447230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Method and device for in vivo tissue regeneration on the interior surface of hollow organs [patent_app_type] => utility [patent_app_number] => 17/963013 [patent_app_country] => US [patent_app_date] => 2022-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6078 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963013 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/963013
Method and device for in vivo tissue regeneration on the interior surface of hollow organs Oct 9, 2022 Issued
Array ( [id] => 18163406 [patent_doc_number] => 20230029999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => RE-TREATMENT FOR OPHTHALMIC CORRECTION OF REFRACTION [patent_app_type] => utility [patent_app_number] => 17/938703 [patent_app_country] => US [patent_app_date] => 2022-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6582 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938703 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/938703
Re-treatment for ophthalmic correction of refraction Oct 6, 2022 Issued
Menu